| human | Q5 |
| P1960 | Google Scholar author ID | vWZ5O1oAAAAJ |
| P6634 | LinkedIn personal profile ID | mchellat |
| P496 | ORCID iD | 0000-0002-3802-672X |
| P69 | educated at | École supérieure de chimie physique électronique de Lyon | Q10178 |
| Ohio State University | Q309331 | ||
| P108 | employer | University of Geneva | Q503473 |
| Swiss Federal Institute of Technology in Lausanne | Q262760 | ||
| Ohio State University | Q309331 | ||
| Scynexis | Q30288657 | ||
| Zurich University of Applied Sciences/ZHAW | Q2605554 | ||
| P735 | given name | Mathieu | Q17484081 |
| Mathieu | Q17484081 | ||
| P106 | occupation | researcher | Q1650915 |
| Q88915094 | A Structural View on Medicinal Chemistry Strategies against Drug Resistance |
| Q87503294 | Domino asymmetric conjugate addition-conjugate addition |
| Q86889626 | Organocatalytic asymmetric annulation of 1,3-bis(alkoxycarbonyl)buta-1,3-dienes and aldehydes |
| Q48088120 | Pseudouridimycin: The First Nucleoside Analogue That Selectively Inhibits Bacterial RNA Polymerase. |
| Q84194099 | Synthesis of key fragments of leiodelide A |
| Q28078130 | Targeting Antibiotic Resistance |
Search more.